Publications by authors named "Nasser Mikhail"

Claim this Profile
I
Innumerable pulmonary nodules.
Brian M Fung, Nasser Mikhail, Peter P Balingit

J Fam Pract· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnic Disparities in Diabetes.
Nasser Mikhail, Soma Wali, Arleen F Brown

Endocrinol Metab Clin North Am· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin U-500, the Practical Solution for the treatment of Patients with High Insulin Requirements.
Nasser Mikhail

Curr Diabetes Rev· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Effects of Liraglutide.
Nasser Mikhail

Curr Hypertens Rev· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Technosphere Inhaled Insulin.
Nasser Mikhail

Curr Drug Saf· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Evolocumab on Cardiovascular Events.
Nasser Mikhail

Curr Cardiol Rev· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Place of technosphere inhaled insulin in treatment of diabetes.
Nasser Mikhail

World J Diabetes· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remogliflozin etabonate: a novel SGLT2 inhibitor for treatment of diabetes mellitus.
Nasser Mikhail

Expert Opin Investig Drugs· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of canagliflozin in patients with type 2 diabetes.
Nasser Mikhail

Curr Drug Saf· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of sodium-glucose cotransporter type 2 inhibitors in older adults with type 2 diabetes mellitus.
Nasser Mikhail

South Med J· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Place of sodium-glucose co-transporter type 2 inhibitors for treatment of type 2 diabetes.
Nasser Mikhail

World J Diabetes· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of incretin-based therapy in patients with heart failure and myocardial infarction.
Nasser Mikhail

Endocrine· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Who would really benefit from DPP-4 inhibitors?
Nasser Mikhail

Endocrine· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of hyperglycemia in hospitalized noncritical patients.
Nasser Mikhail

South Med J· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of dipeptidyl peptidase-4 inhibitors for the treatment of patients with type 2 diabetes mellitus and chronic kidney disease.
Nasser Mikhail

Postgrad Med· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of dipeptidyl peptidase 4 inhibitors for treatment of type 2 diabetes.
Nasser Mikhail

Curr Drug Saf· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quick-release bromocriptine for treatment of type 2 diabetes.
Nasser Mikhail

Curr Drug Deliv· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is liraglutide a useful addition to diabetes therapy?
Nasser E Mikhail

Endocr Pract· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of vitamin D deficiency in primary hyperparathyroidism, and safety of vitamin D therapy.
Nasser Mikhail

South Med J· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhabdomyolysis in an HIV-infected patient on anti-retroviral therapy precipitated by high-dose pravastatin.
Nasser Mikhail, Elizabeth Iskander, Dennis Cope

Curr Drug Saf· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The metabolic syndrome: insulin resistance.
Nasser Mikhail

Curr Hypertens Rep· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LIPID abnormalities in patients infected with human immunodeficiency virus.
Nasser E Mikhail

Endocr Pract· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes.
Nasser Mikhail

Expert Opin Investig Drugs· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burkitt lymphoma presenting with hypercalcemic emergency.
Nasser Mikhail, Shahriar Pirouz, Hena Theile Borneo, Alice Kim, Daniel Kim

South Med J· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why should we avoid the use of rosiglitazone?
Nasser Mikhail

South Med J· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis